The gold standard for quantification of pain is a person's self-report. However, we need objective parameters for pain measurement when intensive care patients are not able to report pain themselves. An increase in pain is currently thought to coincide with an increase in stress hormones. This observational study investigated whether procedure-related pain is associated with an increase of plasma cortisol, adrenaline, and noradrenaline. In 59 patients receiving intensive care after cardiac surgery, cortisol, adrenaline, and noradrenaline plasma levels were measured immediately before and immediately after patients were turned for washing, with or without concurrent removal of drain tubes. Numeric rating scale scores were obtained before, during, and after the procedure. Unacceptably severe pain (numeric rating scale ≥4) was reported by seven (12%), 26 (44%), and nine (15%) patients, before, during and after the procedure, respectively. There was no statistically significant association between numeric rating scale scores and change in cortisol, adrenaline, and noradrenaline plasma levels during the procedure. Despite current convictions that pain coincides with an increase in stress hormones, procedural pain was not associated with a significant increase in plasma stress hormone levels in patients who had undergone cardiac surgery. Thus, plasma levels of cortisol, adrenaline, and noradrenaline seem unsuitable for further research on the measurement of procedural pain.
Key Words: cardiac surgical procedures, chest tubes, adrenaline, hydrocortisone, noradrenaline, pain measurement Effective pain management promotes quality care in the ICU. For example, studies have shown reduced duration of mechanical ventilation 1,2 , shorter ICU and hospital stay, lower 30-day mortality risk 2 and less use of opioids 2 after pain management programs had successfully brought down the incidence of pain. Pain levels are preferably established by the patient's self-report, but observational scales are needed to estimate pain levels in patients who are not capable of selfreport due to sedation, critical illness or neurological disease 3, 4 .
More objective parameters to measure pain have been sought for over 50 years 5 . Changes in heart rate, blood pressure, and respiratory rate have been used as surrogate markers, but especially in ICU patients, these parameters are influenced by disease severity and medication. Measuring skin conductance, which reflects sympathetic nervous system activity, showed higher sympathetic nervous system activity in adult patients with more postoperative pain 6 . The value of skin conductance measurements in intensive care patients remains debatable and only data in paediatric patients have been published 7 . Pain scales such as the Behavioral Pain Scale 3 are included in guidelines for analgesia in ICU patients, although they seem to underestimate pain 4 . Stress hormones, such as cortisol, adrenaline, and noradrenaline, are potentially useful objective parameters of pain, as they are thought to be released systemically in a sympathetic stress response triggered by pain 8, 9 . Although levels of these stress hormones have been related to various types of anaesthesia 10 and depth of sedation 11 in cardiac surgery patients, they have never been studied in relation to procedural pain. ICU patients who have undergone cardiac surgery are inevitably subjected to potentially painful procedures, such as posture change for washing and the removal of chest tubes 12, 13 . Although they experience major surgery assisted with cardiopulmonary bypass, most of them are able to report pain and pain intensity the morning after surgery. In the study reported here, we investigated whether plasma levels of cortisol, adrenaline, and noradrenaline were associated with pain levels due to potentially painful procedures. If this should be the case, these parameters may be of additional value in research on the development of tools to measure pain in patients who are not able to communicate.
Methods

Design & patients
After approval by the local Ethics Committee of the St. Antonius Hospital (Approval No.: R0715A) and study registration at ClinicalTrials.gov (NCT00558090), written informed consent was obtained from 117 patients before surgery. Patients participated in a double-blind, randomised controlled clinical trial on morphine for procedural pain after cardiac surgery, performed in a 30-bed mixed ICU in a teaching hospital in Nieuwegein, The Netherlands 14 . From these patients, 59 participated in the sub-study on stress hormones and procedural pain. Only blood samples from the selected patients, taken during the original study, were analysed for stress hormone levels.
Study procedure
On the first postoperative day, patients received an intravenous bolus dose of morphine of either 2.5 or 7.5 mg 30 minutes before change of posture for washing, combined with chest tube removal (54% of patients), or change of posture only (46% of patients) between 0730 and 0930 14 . Blood samples were taken from the arterial line directly before and after the procedure to determine the levels of cortisol and catecholamines.
Pain levels were recorded before, during, and after the procedure, if possible by the patients themselves on a numeric rating scale (NRS) from 0 to 10. Fifty patients (85%) were able to do this. Nurses assessed the pain for the other nine patients (15%), who were still under residual sedation. The NRS has proven a reliable measure for the estimation of pain in ICU patients 4 . An NRS score ≥4 was considered to represent unacceptable pain 15 and served as a cut-off point for extra analgesia.
Analgesia was protocolised throughout the entire ICU stay, including paracetamol 1000 mg four times daily, morphine via continuous infusion and intravenous morphine boluses as rescue medication. Pain was assessed at least three times a day, and around the procedure on the first postoperative day. Patient characteristics including the European System for Cardiac Operative Risk Evaluation (EuroSCORE) 16 and intraoperative features, such as type of surgery and type of cardiopulmonary bypass (CPB; either conventional or minimal extracorporeal cardiopulmonary bypass), and administration of steroids were recorded.
Biochemical analysis
Arterial blood samples were immediately stored on ice, centrifuged at 4°C, and stored at -80°C. Plasma adrenaline and noradrenaline were assayed by reversed-phase highperformance liquid chromatography with fluorimetric detection after solvent extraction and derivatisation with one 2-diphenylethylenediamine 17 with normal ranges for adrenaline and noradrenaline in awake healthy humans of <655 pmol/l and 0.59 to 3.55 nmol/l, respectively. Plasma cortisol was measured using a luminescence enzyme immunoassay with a normal range for awake healthy humans of 200 to 800 nmol/l at 0900 hours (Immulite 2000, Siemens Healthcare Diagnostics, Malvern, PA, USA).
Statistical analysis
With a power analysis with an overall α=0.05 (two-tailed) and ß=0.20, and an expected small correlation (r=0.20) between the changes in pain scores and changes in cortisol, adrenaline, and noradrenaline plasma levels, showed that at least 58 patients were needed. In this sub-study, 59 patients were randomly selected via the SPSS statistical package (version 19.0 for Windows; SPSS, Chicago, IL, USA) from the 117 patients included in the above-mentioned randomised controlled trial.
As we tested three times for significance (cortisol, adrenaline, and noradrenaline), we adjusted the α-level accordingly (0.05/3=0.01666).
Descriptive statistics of demographic and clinical variables are expressed as frequencies with percentages or median with IQR. Statistical analyses were performed using IBM SPSS Statistics (version 19.0 for Windows; SPSS, Chicago, IL, USA) and SAS (version 9.2, Cary, NC, USA). To eliminate the potential influence of outliers and non-normal distribution of the data, robust regression analysis (procedure MM Estimation) 18 was performed in SAS to test the association between changes in NRS scores ('during the procedure' compared to 'before the procedure') and change in log-transformed values of cortisol, adrenaline, and noradrenaline plasma levels ('after the procedure' compared to 'before the procedure'). This analysis was repeated, adjusting for sex (male coded '0', female coded '1'), age in years, dose of morphine (2.5 mg, coded '0' or 7.5 mg, coded '1'), cardiopulmonary bypass with steroids (coded '0') or without steroids (coded '1'), and the person who scored the pain (patient coded '0', nurse coded '1'). Stress hormone plasma levels before the procedure were covariates in both analyses. Differences were considered significant at a P-level of <0.05 (two-tailed).
Results
Patients and data
Baseline demographics and intraoperative and procedural characteristics of patients are described in Table 1 . The median age was 73 years and males predominated (n=46, 78%). Unacceptable pain during the procedure (NRS ≥4) was reported by 26 patients (44%). Patients who had been on conventional CPB were administered a mean of 48 mg (SD±19) of dexamethasone during CPB.
Cortisol, adrenaline, and noradrenaline plasma levels before and after the potentially painful procedure
Median plasma levels of cortisol, adrenaline and noradrenaline before the procedure were 161 nmol/l (IQR 51 to 572), 1005 pmol/l (IQR 497 to 2217) and 3.49 nmol/l (IQR 2.28 to 4.89), respectively. Values after the procedure were not statistically significantly different from before the procedure-211 nmol/l (IQR 61 to 677), 939 pmol/l (IQR 426 to 1764) and 3.50 nmol/l (IQR 2.38 to 5.27), respectively, P=0.26, 0.24 and 0.19.
Median cortisol and noradrenaline plasma levels before the procedure of patients who had been on conventional CPB (using steroids) were significantly lower than those of patients who had been on minimal extracorporeal cardiopulmonary bypass without the use of steroids ( Five patients had outlying plasma levels of adrenaline (up to 109,200 pmol/l) both before and after the procedure. This could not be explained by inotropes, previous use of monoamine oxidase inhibitors, or otherwise. These patients were not hypertensive during the procedure. Three patients were administered inotropes during or up to two hours before the procedure; one of them showed an exceptionally high level of noradrenaline (53 nmol/l). the change in pain scores during a potentially painful procedure. delta cortisol/adrenaline/noradrenaline=change after the procedure compared to before the procedure in nmol/l(cortisol), pmol/l (adrenaline), and nmol/l (noradrenaline); delta NRS (Numeric Rating Scale)=change in pain score during the procedure compared to before the procedure.
Robust regression analysis of the relation between procedure-related pain levels and changes in cortisol,
adrenaline and noradrenaline levels
The absolute changes of cortisol, adrenaline and noradrenaline plasma levels 'after' compared to 'before' the procedure are shown in the scatter plots ( Figure 1 ). The change in NRS 'during' compared to 'before' the procedure is shown on the x-axis. As can be seen in Figure 1 , patients with an increase in pain due to the procedure could have an increase, decrease or no change in levels of cortisol, adrenaline or noradrenaline. Robust regression analysis did not show a significant association between a change in pain levels and a change in log-transformed plasma levels of cortisol, adrenaline and noradrenaline during the procedure with adjusted stress hormone levels before the procedure (model 1, Table 2 ). After adjusting for stress hormone levels before the procedure, sex, age, morphine dosage, CPB with or without steroids, and 'person who scored the pain' increased the unstandardised regression estimated, but not statistically significantly, with respective estimates of changes in cortisol (B=1.88 [-1.72 to 5.47]), adrenaline (B=1.92 [-0.58 to 4.42]) and noradrenaline (B=0.90 [-1.40 to 3.21] (model 2, Table 2 ).
No differences in the models of Table 2 were found after analysis with and without patients with outlying levels of adrenaline, nor after analysis with and without the three patients who were administered inotropes during or up to two hours before the procedure. No differences were found in the models excluding patients who used steroids preoperatively (n=7); they were therefore included in the models described in Table 2 .
Discussion
Objective parameters to measure pain are essential to diagnose and treat pain in patients who are not able to report pain themselves. In this study, we correlated the change in plasma stress hormones before and after a potentially painful procedure with a change in pain levels reported by patients during this procedure. This study shows that cortisol, adrenaline and noradrenaline plasma levels were not significantly associated with procedural pain in ICU patients after cardiac surgery.
A sympathetic stress response with systemic release of stress hormones triggered by pain is widely suggested in litera-ture 8, 9 . However, studies in humans exploring the association between pain levels and stress hormones are rare. Ledowski et al 19 explored the association between postoperative pain and plasma adrenaline and noradrenaline levels in 85 patients in the post-anaesthetic care unit after minor surgery. Patients were repeatedly asked to rate their pain using the NRS. Plasma levels of adrenaline and noradrenaline in samples taken each time the patient reported a decrease in pain and at discharge from the recovery room did not correlate with NRS scores. The authors concluded that the severity of postoperative pain was not associated with the degree of sympathetic stress response after surgery. These authors studied postoperative patients without additional painful stimuli. From our own study, studying the stress response related to a potentially painful procedure, we have drawn the conclusion that even an increase in pain is not associated with an increase in levels of plasma cortisol and catecholamines.
Myles et al 20 found a significant association between serum levels of cortisol and pain levels at rest in ICU patients 48 hours after cardiac surgery. The authors also compared cortisol levels between two regimens of postoperative analgesia: either continuous intravenous morphine adjusted by the nurse, or morphine via patient-controlled analgesia. Cortisol levels did not differ between the analgesia regimens. It may well be that, within 24 hours after surgery, the mixed effects of tissue trauma, surgical stress, hypothermia during surgery etc, interfere with the effects of postoperative pain on cortisol and catecholamine levels. Furthermore, in the current study, the interval between measurements may have been too short to detect changes in cortisol levels, as procedural pain and not pain at rest was examined.
In a randomised trial comparing patients in the ICU after coronary artery bypass graft, Hall et al 21 found an indication for higher levels of adrenaline, but not noradrenaline or cortisol, in patients who had more pain. However, the randomisation was aimed at different sedation levels, complicating pain measurement.
To our knowledge, only one study related pain during a short painful procedure to the change in stress hormones before and after a procedure. This was a study by Saarenmaa et al 22 in neonates, who received either alfentanil or placebo before Model 1: adjusted for cortisol/adrenaline/noradrenaline value before the procedure. Model 2: adjusted for cortisol/ adrenaline/noradrenaline value before the procedure, sex (0=male, 1=female), age in years, 2.5 (coded 0) or 7.5 mg of morphine (coded 1), cardiopulmonary bypass with steroids (coded 0) or without steroids (coded 1), pain scored by patient (coded 0) or nurse (coded 1). ∆cortisol/adrenaline/noradrenaline=change after the procedure compared to before the procedure. a log-transformed values were used. b 2 values missing. c estimates are unstandardised regression estimates. CI=confidence interval.
tracheal suctioning. Neonates receiving alfentanil had significantly lower behavioural pain scores and significantly lower adrenaline levels; and there was a trend towards lower levels of noradrenaline after the procedure. This study in neonates had to use subjective measurements of pain and they had not undergone major surgery. Using the gold standard for pain measurement, that is self-report, our study could not confirm an association between stress hormone levels and pain.
The patients included in this study participated in a clinical trial in which we evaluated pain levels around a procedure involving turning of the patient, either combined with the removal of chest tubes or not. This setting provided a good opportunity to study patients' self-reported procedural pain in relation to stress hormones. Limitations of this study include the fact that previously used medications (steroids) were not uniform and that the type of surgery, surgical procedure, anaesthesia and type of CPB (with or without the use of steroids) differed. However, the absence of an association between pain and cortisol, adrenaline or noradrenaline levels in these patients, reflecting the average population in our ICU, would render these markers not useful for diagnosing pain.
Conclusion
We conclude that plasma stress hormone levels are not suitable to replace or even support self-reported procedural pain. Moreover, the absence of change in or even a decrease in stress hormones during a painful procedure cannot be seen as a guarantee for the absence of pain. It would be worthwhile to explore other potential surrogate markers to measure pain in patients who cannot communicate. Plasma levels of cortisol, adrenaline and noradrenaline are not suitable for measurement of procedural pain as an endpoint for therapeutic studies.
